Agilent Technologies (A) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
6 Feb, 2026Executive summary
Annual meeting scheduled for March 18, 2026, at 8 a.m. Pacific Time in Santa Clara, CA.
Pre-registration by March 2, 2026, is required to attend the meeting.
Proxy materials and annual report are available online, with options for electronic or paper delivery.
Voting matters and shareholder proposals
Election of four directors for a three-year term: Judy Gawlik Brown, Sue H. Rataj, George A. Scangos, Ph.D., and Dow R. Wilson.
Advisory vote on executive compensation for named executive officers.
Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm.
Approval of an amendment to declassify the Board of Directors over a three-year period.
Board recommends voting FOR all nominees and proposals.
Board of directors and corporate governance
Proposal to declassify the Board of Directors, transitioning to annual elections over three years.
Latest events from Agilent Technologies
- Enterprise transformation, margin growth, and specialty CDMO expansion drive 2026 outlook.A
Citi Annual Global Healthcare Conference 2025 - Strong Q3 growth, margin recovery, and robust outlook driven by innovation and global demand.A
Wells Fargo 20th Annual Healthcare Conference 2025 - Innovation, tech refresh, and AI initiatives fuel strong growth and margin expansion.A
Jefferies Global Healthcare Conference 2026 - Q2 FY26 delivered double-digit revenue growth, margin expansion, and raised guidance.A
Q2 2026 - siRNA manufacturing leadership drives growth in a $4B+ market with expanding capacity and innovation.A
Corporate presentation - Strong growth, innovation, and disciplined strategy support positive outlook for the year.A
TD Cowen 46th Annual Health Care Conference - Q1 FY26 revenue rose 7% to $1.8B, non-GAAP EPS up 4%, and FY26 guidance was raised.A
Q1 2026 - Q4 revenue and EPS exceeded guidance, with FY26 projected for 4%-6% core and 5%-7% EPS growth.A
Q4 2025 - Q2 revenue up 6% and non-GAAP EPS up 7%, with raised FY2025 outlook and operational gains.A
Q2 2025